Regeneron Pharmaceuticals, Inc. (REGN) SEC Filings — 2024
16 SEC filings for Regeneron Pharmaceuticals, Inc. (REGN) in 2024.
Filings
- Regeneron Pharmaceuticals Q3 2024 Update — 10-Q · Oct 31, 2024
- Regeneron Pharmaceuticals Files 8-K on Financials — 8-K · Oct 7, 2024
- Regeneron Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
- Regeneron Pharmaceuticals Files 8-K — 8-K · Jul 8, 2024
- Regeneron Pharmaceuticals Files 8-K on Security Holder Votes — 8-K · Jun 20, 2024
- Regeneron Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- Regeneron Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Apr 25, 2024
- Vanguard Amends Regeneron Stake: Holds 7.6% as of Dec 29, 2023 — SC 13G/A · Feb 13, 2024
- Capital World Investors Trims Regeneron Stake to 4.7% — SC 13G/A · Feb 9, 2024
- FMR LLC Reports 9.63% Stake in Regeneron Pharma — SC 13G/A · Feb 9, 2024
- Regeneron Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 5, 2024
- Regeneron Files 8-K on Financial Results & Operations — 8-K · Feb 2, 2024
- Regeneron 8-K: Executive Comp/Officer Changes Reported Jan 26 — 8-K · Jan 31, 2024
- BlackRock Amends Regeneron Stake; Passive Investment Update — SC 13G/A · Jan 25, 2024
- JPMorgan Amends Regeneron Stake; Passive Ownership Update — SC 13G/A · Jan 25, 2024
- Regeneron Files 8-K on Results, Reg FD Disclosure — 8-K · Jan 8, 2024